메뉴 건너뛰기




Volumn 5, Issue 1, 2000, Pages 89-108

Potential of adenosine receptor agonists for the prevention and treatment of coronary artery disease and acute myocardial infarction

Author keywords

acute myocardial infarction; adenosine agonist; cardioprotection; coronary artery disease; triglycerides

Indexed keywords

4 [7 [[1 [(3 CHLORO 2 THIENYL)METHYL]PROPYL]AMINO] 3H IMIDAZO[4,5 B]PYRIDIN 3 YL] N ETHYL 2,3 DIHYDROXYCYCLOPENTANECARBOXAMIDE; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; 6 N CYCLOHEXYL 2' O METHYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARIPORIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENIPORIDE; FATTY ACID; FIBRIC ACID DERIVATIVE; GP 531; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDR 640; MONOCLONAL ANTIBODY; NICOTINIC ACID; NITRATE; PALLACOR; RG 14202; ROVELIZUMAB; SIMVASTATIN; STATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN; YM 103;

EID: 0034003385     PISSN: 14728214     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728214.5.1.89     Document Type: Article
Times cited : (7)

References (74)
  • 1
    • 84940815279 scopus 로고
    • The physiological activity of adenine compounds with special reference to their action upon the mammalian heart
    • DRURY AN, SZENT-GYÖRGYI A: The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol. (1929) 68:213-237.
    • (1929) J. Physiol. , vol.68 , pp. 213-237
    • Drury, A.N.1    Szent-Györgyi, A.2
  • 3
    • 0028796899 scopus 로고
    • Neurotransmitter receptors VII: Adenosine receptors
    • PALMER TM, STILES GL: Neurotransmitter receptors VII: adenosine receptors. Neuropharmacology (1995) 7:683-694.
    • (1995) Neuropharmacology , vol.7 , pp. 683-694
    • Palmer, T.M.1    Stiles, G.L.2
  • 4
    • 0031593681 scopus 로고    scopus 로고
    • 3 receptors: Novel ligands and paradoxical effects
    • JACOBSON KA: Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol. Sci. (1998) 19:184-191.
    • (1998) Trends Pharmacol. Sci. , vol.19 , pp. 184-191
    • Jacobson, K.A.1
  • 5
    • 0030847083 scopus 로고    scopus 로고
    • Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology
    • SHRYOCK JC, BELARDINELLI L: Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. (1997) 79:2-10.
    • (1997) Am. J. Cardiol. , vol.79 , pp. 2-10
    • Shryock, J.C.1    Belardinelli, L.2
  • 6
    • 0031833150 scopus 로고    scopus 로고
    • Adenosine receptors: New opportunities for future drugs
    • POULSEN S-A, QUINN RJ: Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem. (1998) 6:619-641.
    • (1998) Bioorg. Med. Chem. , vol.6 , pp. 619-641
    • Poulsen, S.-A.1    Quinn, R.J.2
  • 7
    • 0025349998 scopus 로고
    • 2 receptors that promote chemotaxis and inhibit O2-generation, respectively
    • CRONSTEIN BN, DAGUMA L, NICHOLS D, HUTCHINSON AJ, WILLIAMS M: The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2-generation, respectively. J. Clin. Invest. (1990) 85:1150-1157.
    • (1990) J. Clin. Invest. , vol.85 , pp. 1150-1157
    • Cronstein, B.N.1    Daguma, L.2    Nichols, D.3    Hutchinson, A.J.4    Williams, M.5
  • 8
    • 0030614436 scopus 로고    scopus 로고
    • 2 receptor activation attenuates reperfu-sion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence
    • JORDAN JE, ZHAO Z, SATO H, VINTEN-JOHANSEN J: Adenosine A2 receptor activation attenuates reperfu-sion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J. Pharmacol. Exp. Ther. (1997) 280:301-309.
    • (1997) J. Pharmacol. Exp. Ther. , vol.280 , pp. 301-309
    • Jordan, J.E.1    Zhao, Z.2    Sato, H.3    Vinten-Johansen, J.4
  • 9
    • 0017848013 scopus 로고
    • Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactiva-tion on lipolysis in rat fat cells
    • FREDHOLM BB: Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactiva-tion on lipolysis in rat fat cells. Acta Physiol. Scand. (1978) 102:191-198.
    • (1978) Acta Physiol. Scand. , vol.102 , pp. 191-198
    • Fredholm, B.B.1
  • 10
    • 0027318715 scopus 로고
    • Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236
    • STRONG P, ANDERSON R, COATES J et al.: Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236. Clin. Sci. (1993) 84:663-669.
    • (1993) Clin. Sci. , vol.84 , pp. 663-669
    • Strong, P.1    Anderson, R.2    Coates, J.3
  • 11
    • 0018332228 scopus 로고
    • 6-disubst-ituted adenosine derivative (B.M. 11.189) on fat cell metabolism
    • WIESER PB, PENDLETON TS: Effects of an N6-disubst-ituted adenosine derivative (B.M. 11.189) on fat cell metabolism. Biochem. Pharmacol. (1979) 28:693-694.
    • (1979) Biochem. Pharmacol. , vol.28 , pp. 693-694
    • Wieser, P.B.1    Pendleton, T.S.2
  • 13
    • 0014666301 scopus 로고
    • Increased plasma-free-fatty acid concentrations and their significance in patients with acute myocardial infarction
    • GUPTA DK, JEWITT DE, YOUNG R, HARTOG M, OPIE LH: Increased plasma-free-fatty acid concentrations and their significance in patients with acute myocardial infarction. Lancet (1969) 2:1209-1213.
    • (1969) Lancet , vol.2 , pp. 1209-1213
    • Gupta, D.K.1    Jewitt, D.E.2    Young, R.3    Hartog, M.4    Opie, L.H.5
  • 14
    • 0029068815 scopus 로고
    • Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge?
    • VAN DE WERF, F: Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge? Circulation (1995) 91:2862-2864.
    • (1995) Circulation , vol.91 , pp. 2862-2864
    • Van De Werf, F.1
  • 16
    • 0028929031 scopus 로고
    • Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction
    • CHAREONTHAITAWEE P, CHRISTIAN TF, HIROSE K, GIBBONS RJ, RUMBERGER JA: Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J. Am. Coll. Cardiol. (1995) 25:567-573.
    • (1995) J. Am. Coll. Cardiol. , vol.25 , pp. 567-573
    • Chareonthaitawee, P.1    Christian, T.F.2    Hirose, K.3    Gibbons, R.J.4    Rumberger, J.A.5
  • 17
    • 0031856855 scopus 로고    scopus 로고
    • Adjunctive therapy after reperfusion therapy in acute myocardial infarction
    • DRIES DL, SOLOMON AJ, GERSH BJ: Adjunctive therapy after reperfusion therapy in acute myocardial infarction. Clin. Cardiol. (1998) 21:379-386.
    • (1998) Clin. Cardiol. , vol.21 , pp. 379-386
    • Dries, D.L.1    Solomon, A.J.2    Gersh, B.J.3
  • 18
    • 0030869951 scopus 로고    scopus 로고
    • Adjunctive therapy for acute myocardial infarction
    • ALEXANDER J: Adjunctive therapy for acute myocardial infarction. Curr. Opin. Cardiol. (1997) 12:453-458.
    • (1997) Curr. Opin. Cardiol. , vol.12 , pp. 453-458
    • Alexander, J.1
  • 19
    • 0029024202 scopus 로고
    • Myocardial reperfusion injury: Experimental evidence and clinical relevance
    • HANSEN PR: Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur. Heart J. (1995) 16:734-740.
    • (1995) Eur. Heart J. , vol.16 , pp. 734-740
    • Hansen, P.R.1
  • 20
    • 0025944674 scopus 로고
    • Reperfusion induced injury. Manifestations, mechanisms and clinical relevance
    • HEARSE DJ, BOLLI R: Reperfusion induced injury. Manifestations, mechanisms and clinical relevance. Trends Cardiovasc. Med. (1991) 1:233-240.
    • (1991) Trends Cardiovasc. Med. , vol.1 , pp. 233-240
    • Hearse, D.J.1    Bolli, R.2
  • 21
    • 0028946762 scopus 로고
    • Physiologic mechanisms of postischemic tissue injury
    • GRANGER DN, KORTHUIS RJ: Physiologic mechanisms of postischemic tissue injury. Ann. Rev. Physiol. (1995) 57:311-332.
    • (1995) Ann. Rev. Physiol. , vol.57 , pp. 311-332
    • Granger, D.N.1    Korthuis, R.J.2
  • 22
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia
    • SHEPHERD J, COBBE ASM, FORD et al.: Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia. N. Engl. J. Med. (1995) 333:1301-1307.
    • (1995) N. Engl. J. Med. , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Asm, C.2    Ford3
  • 23
    • 0027987849 scopus 로고
    • Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin survival study
    • SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP
    • SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin survival study. Lancet (1994) 344:1383-1389.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 24
    • 0002746856 scopus 로고
    • Serum triglycerides in coronary artery disease
    • ALBRINK M, MAN EB: Serum triglycerides in coronary artery disease. Arch. Int. Med. (1959) 103:4-8.
    • (1959) Arch. Int. Med. , vol.103 , pp. 4-8
    • Albrink, M.1    Man, E.B.2
  • 25
    • 0001630654 scopus 로고
    • Serum triglycerides in health and in ischemic heart disease
    • BROWN DF, KINCH SH, DOYLE JT: Serum triglycerides in health and in ischemic heart disease. N. Engl. J. Med. (1965) 273:947-952.
    • (1965) N. Engl. J. Med. , vol.273 , pp. 947-952
    • Brown, D.F.1    Kinch, S.H.2    Doyle, J.T.3
  • 26
    • 0033551386 scopus 로고    scopus 로고
    • Epidemiology of hypertriglyceridemia and cardiovascular disease
    • AUSTIN MA: Epidemiology of hypertriglyceridemia and cardiovascular disease. Am. J. Cardiol. (1999) 83:13F-16F.
    • (1999) Am. J. Cardiol. , vol.83
    • Austin, M.A.1
  • 27
    • 0033056375 scopus 로고    scopus 로고
    • Treating patients with hypertriglyc-eridemia saves lives: Triglyceride revisited
    • MOONEY A: Treating patients with hypertriglyc-eridemia saves lives: triglyceride revisited. Curr. Med. Res. Opin. (1999) 15:65-77.
    • (1999) Curr. Med. Res. Opin. , vol.15 , pp. 65-77
    • Mooney, A.1
  • 28
    • 0345620788 scopus 로고    scopus 로고
    • Hypertriglyceridemia: Changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease
    • BREWER HB: Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am. J. Cardiol. (1999) 83:3F-12F.
    • (1999) Am. J. Cardiol. , vol.83
    • Brewer, H.B.1
  • 29
    • 0029618375 scopus 로고
    • Linking research strategies to market opportunities for new cardiovascular drugs
    • MAGGON KK: Linking research strategies to market opportunities for new cardiovascular drugs. Drugs News Perspect. (1995) 8:560-571.
    • (1995) Drugs News Perspect. , vol.8 , pp. 560-571
    • Maggon, K.K.1
  • 30
    • 0029804941 scopus 로고    scopus 로고
    • ACC/AHA Guidelines for the management of patients with acute myocardial infarction: Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
    • RYAN TJ, ANDERSON JL: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation (1996) 94:2341-2350.
    • (1996) Circulation , vol.94 , pp. 2341-2350
    • Ryan, T.J.1    Anderson, J.L.2
  • 32
    • 0030848709 scopus 로고    scopus 로고
    • Phenotype expression in familial combined hyperlipidemia
    • PORKKA KVK, NUOTIO I, PAJUKANTA et al.: Phenotype expression in familial combined hyperlipidemia. Atherosclerosis (1997) 133:245-253.
    • (1997) Atherosclerosis , vol.133 , pp. 245-253
    • Porkka, K.V.K.1    Nuotio, I.2    Pajukant, A.3
  • 33
    • 0032562257 scopus 로고    scopus 로고
    • Triglyeride concentration and ischemic heart disease: An eight year follow-upinthe Copenhagen male study
    • JEPPESEN J, HEIN HO, SUADICANI P, GYNTELBERG F: Triglyeride concentration and ischemic heart disease: an eight year follow-upinthe Copenhagen male study. Circulation (1998) 97:1029-1036.
    • (1998) Circulation , vol.97 , pp. 1029-1036
    • Jeppesen, J.1    Hein, H.O.2    Suadicani, P.3    Gyntelberg, F.4
  • 34
    • 0032080923 scopus 로고    scopus 로고
    • Normal triglyceride levels and coronary artery disease events: The baltimore coronary observational long-term study
    • MILLER M, SEIDLER A, MOALEMI A, PEARSON TA: Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J. Am. Coll. Cardiol. (1998) 31:1252-1257.
    • (1998) J. Am. Coll. Cardiol. , vol.31 , pp. 1252-1257
    • Miller, M.1    Seidler, A.2    Moalemi, A.3    Pearson, T.A.4
  • 35
    • 0022970945 scopus 로고
    • Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
    • MURRY CE, JENNINGS RB, REIMER KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 74:1124-1136.
    • (1986) Circulation , vol.74 , pp. 1124-1136
    • Murry, C.E.1    Jennings, R.B.2    Reimer, K.A.3
  • 36
    • 0027297849 scopus 로고
    • ATP channels, and ischemic preconditioning in dogs
    • AUCHAMPACH JA, GROSS GJ: Adenosine A1 receptor, KATP channels, and ischemic preconditioning in dogs. Am. J. Physiol. (1993) 264:H1327-H1336
    • (1993) Am. J. Physiol. , vol.264
    • Auchampach, J.A.1    Gross, G.J.2
  • 37
    • 0026700067 scopus 로고
    • Ischemic preconditioning: Nature's own cardioprotective mechanism
    • DOWNEY JM: Ischemic preconditioning: Nature's own cardioprotective mechanism. Trends Cardiovasc. Med. (1992) 2:170-176.
    • (1992) Trends Cardiovasc. Med. , vol.2 , pp. 170-176
    • Downey, J.M.1
  • 38
    • 0029058094 scopus 로고
    • Involvement of endogenous adenosine in ischaemic preconditioning in swine
    • SCHULZ R, ROSE J, POST H, HEUSCH G: Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch. (1995) 430:273-282.
    • (1995) Pflugers Arch. , vol.430 , pp. 273-282
    • Schulz, R.1    Rose, J.2    Post, H.3    Heusch, G.4
  • 39
    • 0032900356 scopus 로고    scopus 로고
    • 1-receptor agonist, in myocar-dial ischaemia-reperfusion injury in the pig
    • LOUTTIT JB, HUNT AAE, MAXWELL MP, DREW GM: The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocar-dial ischaemia-reperfusion injury in the pig. J. Cardio-vasc. Pharmacol. (1999) 33:285-291.
    • (1999) J. Cardio-vasc. Pharmacol. , vol.33 , pp. 285-291
    • Louttit, J.B.1    Aae, H.2    Maxwell, M.P.3    Drew, G.M.4
  • 40
    • 0026548414 scopus 로고
    • 2-receptor agonistsonmyocardial reperfusion injury
    • NORTON ED, JACKSON EK, TURNER MB, VIRMANI R, FORMAN MB: The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonistsonmyocardial reperfusion injury. Am. Heart J. (1992) 123:332-338.
    • (1992) Am. Heart J. , vol.123 , pp. 332-338
    • Norton, E.D.1    Jackson, E.K.2    Turner, M.B.3    Virmani, R.4    Forman, M.B.5
  • 41
    • 0027336240 scopus 로고
    • 2 receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart
    • SCHLACK W, SCHÄFER M, UEBING A, SCHÄFER S, BORCHARD U, THÄMER V: Adenosine A2 receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J. Cardiovasc. Pharmacol. (1993) 22:89-96.
    • (1993) J. Cardiovasc. Pharmacol. , vol.22 , pp. 89-96
    • Schlack, W.1    Schäfer, M.2    Uebing, A.3    Schäfer, S.4    Borchard, U.5    Thämer, V.6
  • 42
    • 0032499689 scopus 로고    scopus 로고
    • 3 receptor: Sustained cardioprotection
    • LIANG BT, JACOBSON KA: A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc. Natl. Acad. Sci. USA (1998) 95:6995-6999.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 6995-6999
    • Liang, B.T.1    Jacobson, K.A.2
  • 43
    • 0030615054 scopus 로고    scopus 로고
    • 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart
    • TRACEY WR, MAGEE W, MASAMUNE H et al.: Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc. Res. (1997) 33:410-415.
    • (1997) Cardiovasc. Res. , vol.33 , pp. 410-415
    • Tracey, W.R.1    Magee, W.2    Masamune, H.3
  • 44
    • 0028849820 scopus 로고
    • Cardiovascular and antilipolytic effects of the adenosine agonist GR79236
    • MERKEL LA, HAWKINS ED, COLUSSI DJ et al.: Cardiovascular and antilipolytic effects of the adenosine agonist GR79236. Pharmacology (1995) 51:224-236.
    • (1995) Pharmacology , vol.51 , pp. 224-236
    • Merkel, L.A.1    Hawkins, E.D.2    Colussi, D.J.3
  • 45
    • 0028906835 scopus 로고
    • General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist
    • WAGNER H, MILAVEC-KRIZMAN M, GADIENT F et al.: General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist. Drug Dev. Res. (1995) 34:276-288.
    • (1995) Drug Dev. Res. , vol.34 , pp. 276-288
    • Wagner, H.1    Milavec-Krizman, M.2    Gadient, F.3
  • 47
    • 0032444747 scopus 로고    scopus 로고
    • 2 receptor agonist and cardioprotective
    • MERKEL L, ROJAS CJ, JARVIS MF et al.: Pharmacological characterization of AMP 579, A novel adenosine A1/A2 receptor agonist and cardioprotective. Drug Dev. Res. (1998) 45:30-43.
    • (1998) Drug Dev. Res. , vol.45 , pp. 30-43
    • Merkel, L.1    Rojas, C.J.2    Jarvis, M.F.3
  • 48
    • 0022908516 scopus 로고
    • Suppression of free fatty acids and triglyc-erides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladeno-sine
    • HOFFMAN B, DALL'AGLIO E, HOLLENBECK C, CHANG H, REAVEN G: Suppression of free fatty acids and triglyc-erides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladeno-sine. J. Pharmacol. Exp. Ther. (1986) 239:715-718.
    • (1986) J. Pharmacol. Exp. Ther. , vol.239 , pp. 715-718
    • Hoffman, B.1    Dall'Aglio, E.2    Hollenbeck, C.3    Chang, H.4    Reaven, G.5
  • 49
    • 0032542388 scopus 로고    scopus 로고
    • Effect of niacin on atherosclerotic cardiovascular disease
    • GUYTON JR: Effect of niacin on atherosclerotic cardiovascular disease. Am. J. Cardiol. (1998) 82:18U-23U.
    • (1998) Am. J. Cardiol. , vol.82
    • Guyton, J.R.1
  • 50
    • 0000759802 scopus 로고    scopus 로고
    • Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial
    • MAHAFFEY KW, PUMA JA, BARBAGELATA A et al.: Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial. Circulation (1997) 96 (S1):206-207.
    • (1997) Circulation , vol.96 , Issue.S1 , pp. 206-207
    • Mahaffey, K.W.1    Puma, J.A.2    Barbagelata, A.3
  • 51
    • 0030740126 scopus 로고    scopus 로고
    • Role of adenosine in the cardiac catheteri-zation laboratory
    • OGILBY JD: Role of adenosine in the cardiac catheteri-zation laboratory. Am. J. Cardiol. (1997) 79:15-19.
    • (1997) Am. J. Cardiol. , vol.79 , pp. 15-19
    • Ogilby, J.D.1
  • 52
    • 0030795989 scopus 로고    scopus 로고
    • Myocardial perfusion imaging during adenosine-induced coronary hyperemia
    • ISKANDRIAN AE, JAEKYEONG H: Myocardial perfusion imaging during adenosine-induced coronary hyperemia. Am. J. Cardiol. (1997) 79:20-24.
    • (1997) Am. J. Cardiol. , vol.79 , pp. 20-24
    • Iskandrian, A.E.1    Jaekyeong, H.2
  • 53
  • 54
    • 0030871604 scopus 로고    scopus 로고
    • Adenosine for myocardial protection in acute myocardial infarction
    • GRANGER CB: Adenosine for myocardial protection in acute myocardial infarction. Am. J. Cardiol. (1997) 79:44-48.
    • (1997) Am. J. Cardiol. , vol.79 , pp. 44-48
    • Granger, C.B.1
  • 55
    • 0031854292 scopus 로고    scopus 로고
    • Intravenous adenosine and lidocaine in patients with acute myocardial infarction
    • GARRATT KN, HOLMES DR, MOLINA-VIAMONTE V et al.: Intravenous adenosine and lidocaine in patients with acute myocardial infarction. Am. Heart J. (1998) 136:196-204.
    • (1998) Am. Heart J. , vol.136 , pp. 196-204
    • Garratt, K.N.1    Holmes, D.R.2    Molina-Viamonte, V.3
  • 56
  • 57
    • 0030971672 scopus 로고    scopus 로고
    • Preconditioning of human myocardium with adenosine during coronary angioplasty
    • LEESAR MA, STODDARD M, AHMED M, BROADBENT J, BOLLI R: Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation (1997) 95:2500-2507.
    • (1997) Circulation , vol.95 , pp. 2500-2507
    • Leesar, M.A.1    Stoddard, M.2    Ahmed, M.3    Broadbent, J.4    Bolli, R.5
  • 58
    • 0032941838 scopus 로고    scopus 로고
    • 2 receptor agonist, AMP 579; Coronary hemodynamic and cardioprotective activityin canine myocardium
    • MCVEY M, SMITS GJ, KITZEN J, CLARK KL, PERRONE MH: Cardiovascular pharmacology of the adenosine A1/A2 receptor agonist, AMP 579; coronary hemodynamic and cardioprotective activityin canine myocardium. J. Cardiovasc. Pharmacol. (1999) 33:703-710.
    • (1999) J. Cardiovasc. Pharmacol. , vol.33 , pp. 703-710
    • McVey, M.1    Smits, G.J.2    Kitzen, J.3    Clark, K.L.4    Perrone, M.H.5
  • 59
    • 0032423596 scopus 로고    scopus 로고
    • 2 receptor agonist, AMP 579, in a porcine model of myocardial infarction
    • SMITS GJ, MCVEY M, COX BF, PERRONE MH, CLARK KL: Cardioprotective effects of the novel adenosine A1/A2 receptor agonist, AMP 579, in a porcine model of myocardial infarction. J. Pharmacol. Exp. Ther. (1998) 286:611-618.
    • (1998) J. Pharmacol. Exp. Ther. , vol.286 , pp. 611-618
    • Smits, G.J.1    McVey, M.2    Cox, B.F.3    Perrone, M.H.4    Clark, K.L.5
  • 60
    • 0007298731 scopus 로고    scopus 로고
    • A novel adenosine analog AMP 579 inhibits neutrophil activation, adherence and neutrophil mediated injury to coronary vascular endothelium
    • NAKAMURA M, ZHAO Z, CLARK KL, GUYTON RA, VINTEN-JOHANSEN J: A novel adenosine analog AMP 579 inhibits neutrophil activation, adherence and neutrophil mediated injury to coronary vascular endothelium. Circulation (1998) 98:I-666.
    • (1998) Circulation , vol.98
    • Nakamura, M.1    Zhao, Z.2    Clark, K.L.3    Guyton, R.A.4    Vinten-Johansen, J.5
  • 61
    • 80052091286 scopus 로고    scopus 로고
    • AMP 579 induces prolonged protection against myocardial infarction in minipig
    • MENG H, McVEY M, PERRONE M, CLARK KL: AMP 579 induces prolonged protection against myocardial infarction in minipig. J. Mol. Cell Cardiol. (1999) 31:A12.
    • (1999) J. Mol. Cell Cardiol. , vol.31
    • Meng, H.1    McVey, M.2    Perrone, M.3    Clark, K.L.4
  • 62
    • 0033307237 scopus 로고    scopus 로고
    • Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers
    • ZANNIKOS PN, BAYBUTT RI, BOUTOUYRIE BX, SHAH B, HUNT TL, JENSEN BK: Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers. J. Clin. Pharmacol. (1999) 39:1-9.
    • (1999) J. Clin. Pharmacol. , vol.39 , pp. 1-9
    • Zannikos, P.N.1    Baybutt, R.I.2    Boutouyrie, B.X.3    Shah, B.4    Hunt, T.L.5    Jensen, B.K.6
  • 63
    • 0031021506 scopus 로고    scopus 로고
    • Effects of acadesine on myocardial infarction, stroke, and death following surgery
    • MANGANO DT: Effects of acadesine on myocardial infarction, stroke, and death following surgery. JAMA (1997) 277:325-333.
    • (1997) JAMA , vol.277 , pp. 325-333
    • Mangano, D.T.1
  • 64
    • 0032774426 scopus 로고    scopus 로고
    • The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusioninjury. from amiloridetocariporide
    • KARMAZYN M: The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusioninjury. From amiloridetocariporide.Ann. NY Acad. Sci. (1999) 874:326-334.
    • (1999) Ann. NY Acad. Sci. , vol.874 , pp. 326-334
    • Karmazyn, M.1
  • 65
    • 0031940890 scopus 로고    scopus 로고
    • Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury
    • ELLIOTT GT: Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J. Mol. Cell Cardiol. (1998) 30:3-17.
    • (1998) J. Mol. Cell Cardiol. , vol.30 , pp. 3-17
    • Elliott, G.T.1
  • 66
    • 9444258047 scopus 로고    scopus 로고
    • Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction
    • SCHAER GL, SPACCAVENTO LJ, BROWNE KFet al.: Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Circulation (1996) 94:298-307.
    • (1996) Circulation , vol.94 , pp. 298-307
    • Schaer, G.L.1    Spaccavento, L.J.2    Browne, K.F.3
  • 67
    • 0033031710 scopus 로고    scopus 로고
    • Effect of adenosine on heart rate variability in humans
    • RONGEN GA, BROOKS SC, POLLARD MJ et al.: Effect of adenosine on heart rate variability in humans. Clin. Sci. (1999) 96:597-604.
    • (1999) Clin. Sci. , vol.96 , pp. 597-604
    • Rongen, G.A.1    Brooks, S.C.2    Pollard, M.J.3
  • 68
    • 85047680481 scopus 로고
    • 1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischemia
    • ZHAO ZQ, NAKANISHI K, MCGEE DS, TAN P, VINTEN-JOHANSEN J: A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischemia. Cardiovasc. Res. (1994) 28:270-279.
    • (1994) Cardiovasc. Res. , vol.28 , pp. 270-279
    • Zhao, Z.Q.1    Nakanishi, K.2    McGee, D.S.3    Tan, P.4    Vinten-Johansen, J.5
  • 69
    • 0027264787 scopus 로고
    • Functional characterization of three adenosine receptor subtypes
    • GURDEN MF, COATES J, ELLIS F et al.: Functional characterization of three adenosine receptor subtypes. Br. J. Pharmacol. (1993) 109:693-698.
    • (1993) Br. J. Pharmacol. , vol.109 , pp. 693-698
    • Gurden, M.F.1    Coates, J.2    Ellis, F.3
  • 70
    • 0030783720 scopus 로고    scopus 로고
    • 1 receptor in vivo
    • VAN SCHAICK EA, MATHÔT RAA, GUBBNES-STIBBE JM et al.: 8-Alkylamino-substituted analogs of N6-cyclopent-yladenosine are partial agonists for the cardiovascular adenosine A1 receptor in vivo. J. Pharmacol. Exp. Ther. (1997b) 283:800-808.
    • (1997) J. Pharmacol. Exp. Ther. , vol.283 , pp. 800-808
    • Van Schaick, E.A.1    Raa, M.2    Gubbnes-Stibbe, J.M.3
  • 72
    • 0028239364 scopus 로고
    • The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat
    • GARDNER CJ, TWISSELL DJ, COATES J, STRONG P: The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat. Eur. J. Pharmacol. (1994) 257:117-121.
    • (1994) Eur. J. Pharmacol. , vol.257 , pp. 117-121
    • Gardner, C.J.1    Twissell, D.J.2    Coates, J.3    Strong, P.4
  • 74
    • 17544383117 scopus 로고    scopus 로고
    • Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors
    • PALMER TM, BENOVIC JL, STILES GL: Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. J. Biol. Chem. (1996) 271:15272-15278.
    • (1996) J. Biol. Chem. , vol.271 , pp. 15272-15278
    • Palmer, T.M.1    Benovic, J.L.2    Stiles, G.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.